In 2023, Black adults received only about 12 percent of prescriptions for popular anti-obesity drugs, while 85 percent went to White patients.21 This stark disparity underscores systemic inequities in the healthcare system, from provider bias to financial barriers, that disproportionately affect communities of color
These treatments are perfect for restoring facial definition lost during weight loss
Next-generation weight management solution to reduce food cravings, promote feeling full more quickly, and keep you feeling satisfied longer by activating multiple GLP-1 receptors
Keep the muscle, lose the fat Develop healthy habits Find support in community Ask your 1:1 coach anything Leadership and Advocacy Noom is setting the standard for ethical, evidence-based GLP-1 care
Our role is to prepare tissue with non-invasive device treatments that improve vascularity and dermal quality, and to maintain results afterwards
In a substudy of 178 patients from the SUSTAIN 8 trial on semaglutide as a diabetes treatment, the average proportion of lean mass loss was nearly identical at 40%, despite lower doses and less total weight loss than in the STEP 1 trial
